Title: Intellikine
Description: Intellikine is a private, La Jolla-based biotherapeutics company, with a mission to discover and develop novel, small molecule drugs that target signal transduction networks for the treatment of cancer, inflammation and autoimmune diseases.
Keywords:biotech, pharmaceutical, drug, biotechnology, biopharmaceutical, phosphoinositide 3-kinase, phosphatidylinositol-3-kinase, PI3K/Akt/mTOR pathway, PI-3 kinase, PI3kinase, dial-in/out, dial-in, dial-out, potency, selectivity, drug candidate, pipeline, small molecule therapies, La Jolla, California, Troy E. Wilson, Christian Rommel, Kevan M. Shokat, Bart Vanhaesebroeck, Neil Rosen,
... (View More)
Kapil Dhingra, PI3Kalpha, PI3Kbeta, PI3Kdelta, PI3Kgamma, mTOR, mammalian target of rapamycin, kinase, drug discovery, drug development, clinical trial, partnering, partnership, target signal transduction networks, cancer, inflammation and autoimmune diseases, cell proliferation, growth, motility, metabolism, and survival, Abingworth, CMEA, Sofinnova, Rheumatoid arthritis RA, systemic lupus erythematosus SLE, multiple sclerosis MS, allergy, asthma, Graft-versus-host disease GvHD and hematopoie, solid tumors, allergic diseases, COPD, BEZ-235, PI-103, GDC-0941, GDC0941, BEZ235, PP-242, wortmannin, LY294002(View Less)
+
0%) - 
